Maryam Kazerani

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Pre-treatment T cell features and immune-milieu characteristics shape treatment-induced exhaustion and resistance to Blinatumomab in B-cell acute lymphoblastic leukemia.

Pre-treatment T cell features and immune-milieu characteristics shape treatment-induced exhaustion and resistance to Blinatumomab in B-cell acute lymphoblastic leukemia.

Journal: Frontiers in immunology

Published: May 30, 2026

Pre-vaccine immune profiling in cancer patients identifies correlates of COVID-19 vaccine responses.

Pre-vaccine immune profiling in cancer patients identifies correlates of COVID-19 vaccine responses.

Journal: Human vaccines & immunotherapeutics

Published: December 16, 2025

TP53 deficiency in AML induces resistance to T-cell engagers through an immunosuppressive secretome.

TP53 deficiency in AML induces resistance to T-cell engagers through an immunosuppressive secretome.

Journal: Leukemia

Published: December 10, 2025

TNF-α and IFN-γ differentially regulate AML cell susceptibility to CD70-antibody-mediated cytotoxicity.

TNF-α and IFN-γ differentially regulate AML cell susceptibility to CD70-antibody-mediated cytotoxicity.

Journal: Journal for immunotherapy of cancer

Published: November 17, 2025

FLT3-directed BiTE Molecules versus CAR T Cells in AML: Co-stimulatory Signals Mitigate T-Cell Exhaustion.

FLT3-directed BiTE Molecules versus CAR T Cells in AML: Co-stimulatory Signals Mitigate T-Cell Exhaustion.

Journal: Blood advances

Published: August 22, 2025

FLT3-directed BiTE molecules vs CAR T cells in AML: costimulatory signals mitigate T-cell exhaustion.

FLT3-directed BiTE molecules vs CAR T cells in AML: costimulatory signals mitigate T-cell exhaustion.

Journal: Blood advances

Published: August 22, 2025

FLT3-directed BiTE molecules vs CAR T cells in AML: costimulatory signals mitigate T-cell exhaustion.

FLT3-directed BiTE molecules vs CAR T cells in AML: costimulatory signals mitigate T-cell exhaustion.

Journal: Blood advances

Published: August 22, 2025

Histone methyltransferase SETDB1 safeguards mouse fetal hematopoiesis by suppressing activation of cryptic enhancers.

Histone methyltransferase SETDB1 safeguards mouse fetal hematopoiesis by suppressing activation of cryptic enhancers.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: December 17, 2024

Evolution of T-cell fitness through AML progression: enhanced bispecific T-cell engager-mediated function of bone marrow T cells at remission compared to initial diagnosis and relapse.

Evolution of T-cell fitness through AML progression: enhanced bispecific T-cell engager-mediated function of bone marrow T cells at remission compared to initial diagnosis and relapse.

Journal: Leukemia

Published: March 13, 2024

Adapter CAR T cells to counteract T-cell exhaustion and enable flexible targeting in AML.

Adapter CAR T cells to counteract T-cell exhaustion and enable flexible targeting in AML.

Journal: Leukemia

Published: January 15, 2023

T-cell exhaustion induced by continuous bispecific molecule exposure is ameliorated by treatment-free intervals.

T-cell exhaustion induced by continuous bispecific molecule exposure is ameliorated by treatment-free intervals.

Journal: Blood

Published: March 21, 2022

Promoter G-quadruplexes and transcription factors cooperate to shape the cell type-specific transcriptome.

Promoter G-quadruplexes and transcription factors cooperate to shape the cell type-specific transcriptome.

Journal: Nature communications

Published: August 14, 2020

Showing 1-12 of 15

Last Updated: 09/26/2026